Successful management using combination therapy of endotoxin absorption therapy (PMX) and continuous hemodiafiltration (CVVHDF) of a critically ill burn patient suffering from methicillin-resistant Staphylococcus aureus toxic shock syndrome

Burns

Volumn 34, Issue 2, 2008, Pages 288-291

  Nakazawa, Hiroaki ^a   Nozaki, Motohiro ^b   Shimoda, Katsumi ^a   Kikuchi, Yuji ^b   Honda, Takashi ^b   Isago, Tsukasa ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATINE KINASE; CREATININE; DOPAMINE; ENDOTOXIN; GABEXATE MESILATE; IMMUNOGLOBULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; NITROGEN; NORADRENALIN; POLYMYXIN; RINGER LACTATE SOLUTION; UREA; VANCOMYCIN;

ADULT; ARTICLE; BODY REGIONS; BODY SURFACE; BURN; BURN INFECTION; CASE REPORT; CLINICAL FEATURE; CRITICAL ILLNESS; DESQUAMATION; DIARRHEA; DISEASE COURSE; DRUG WITHDRAWAL; FEVER; HEMODIAFILTRATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RASH; REHABILITATION CARE; RESUSCITATION; SYSTOLIC BLOOD PRESSURE; THROMBOCYTOPENIA; TOXIC SHOCK SYNDROME; TREATMENT OUTCOME; URINE VOLUME;

ABSORPTION; BURNS; COMBINED MODALITY THERAPY; CRITICAL ILLNESS; ENDOTOXINS; HEMOFILTRATION; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 38549164820     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2006.11.018     Document Type: Article

References (23)

1. Frame J.D., Eve M.D., and Hackett M.E.J. The toxic shock syndrome in burned children. Burns 11 (1985) 234-241
2. Farmer B., Bradley J., and Smiley P. Toxic shock syndrome in a scald burn victim. J Trauma 25 (1985) 1004-1006
3. Cole R., and Shakepeare P. Toxic shock syndrome in scalded children. Burns 16 (1990) 221-224
4. Heywood A.J., and Al-Essa S. Toxic shock syndrome in child with only 2% burns. Lancet 335 (1990) 867
5. McAllister R.M., Mercer N.S., Morgan B.D., and Sanders R. Early diagnosis of staphylococcal toxaemia in burned children. Burns 19 (1993) 22-25
6. Bacha E.A., Sheridan R.I., Donohue G.A., and Tompkins R.G. Staphylococcal toxic shock syndrome in a paediatric burn unit. Burns 20 (1994) 499-502
7. Blomqvist L. Toxic shock syndrome after burn injuries in children. Scand J Plast Reconstr Surg Hand Surg 31 (1996) 77-81
8. Johnson D., and Pathirana P.D.R. Toxic shock syndrome following cessation of prophylactic antibiotics in a child with a 2% scald. Burns 28 (2002) 181-184
9. Withey S.J., Carver N., Frame J.D., and Walker C.C. Toxic shock syndrome in adults burns. Burns 25 (1999) 659-662
10. Fujioka M., Nishimura G., Hamada Y., Sakai T., Miyazato O., and Yamamoto T. Fatal possible toxic shock syndrome in an adult following 15% scald burn. Burns 30 (2004) 181-184
11. Frame J., Bird D., Eve M.D., and Webster ADl. IgG subclass levels in thermally injured children. Scand J Plast Reconstr Surg Hand Surg 21 (1987) 323-326
12. Bergdoll M.S., Crass B.A., Reiser R.F., Robbins R.N., and Davis J.P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet i (1981) 1017-1021
13. Hajjeh R.A., Reingold A., Weil A., Shutt K., Schuchat A., and Perkins B.A. Toxic shock syndrome in the United States: surveillance update, 1979-1999. Emerg Infect Dis 5 (1999) 807-810
14. Aoki H., Kodama M., Tani T., and Hanasawa K. Treatment of sepsis by extracorporeal elimitation of endotoxin using polymyxin B-immobilized fiber. Am J Surg 167 (1994) 412-417
15. Tani T., Hanazawa K., Endo Y., and Kodama M. The efficacy and limit of endotoxin absorbing therapy on the multiple organ failure. ICU&CCU 19 (1995) 797-804
16. Shimaoka H., Nakada K., Atagi K., Nakasuji M., Takagi O., and Satani M. The efficacy of endotoxin absorbing therapy. ICU&CCU 20 (1996) 693-698
17. Shoji H., Tani T., Hanasawa K., and Kodama M. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application. Ther Apher 2 (1998) 3-12
18. Nakazawa H., Kikuchi Y., Honda T., Isago T., Nozaki M., and Morioka K. Successful management of a critically ill burn patient suffering sepsis by use of endotoxin absorption therapy (PMX). Burns 30 (2004) 276-279
19. Varga K., Wagner J.A., Bridgen T., and Kunos G. Platelet-and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12 (1998) 1035-1044
20. Wang Y., Liu Y., Sarker K., Nakashima M., Serizawa T., and Kishida A. Polymyxin B binds to anadamide and inhibits its cytotoxic effect. FEBS Lett 470 (2000) 151-155
21. Tsuruzono K., Inoue K., Harunari N., Yamashita K., Mega K., and Ueyama M. Endotoxin absorption therapy for extensively burned patients. ICU&CCU 24 (2000) 913-919
22. Fujita N., Mouri T., Yamashita T., Itoh E., Sugihawa M., and Hirahara K. The mechanism of efficacy of endotoxin absorption. ICU&CCU 24 (2000) 881-889
23. Ikeda T., Ikeda K., Onizuka T., Suzuki H., Suzuki K., and Ohashi H. When should we consider blood absorption therapy using polymyxin B-immobilized fibers for septic shock patients?. ICU&CCU 24 (2000) 891-897